|
|||||
|
|
Long-term outcomes in temporal lobe epilepsy with glutamate decarboxylase antibodies |
|
| Authors: | Joubert Bastien Belbezier Aude Haesebaert Julie Rheims Sylvain Ducray François Picard Géraldine Rogemond Véronique Psimaras Dimitri Berzero Giulia Desestret Virginie Honnorat Jérôme |
| Affiliation: | 1.French Reference Center on Paraneoplastic Neurological Syndromes, Hospices Civils de Lyon, Hôpital Neurologique, 69677, Bron, France ;2.Institut NeuroMyoGene INSERM U1217/CNRS UMR 5310, Université de Lyon, Université Claude Bernard Lyon 1, 69372, Lyon, France ;3.Public Health Department, Hospices Civils de Lyon, 69424, Lyon, France ;4.HESPER, Université de Lyon, Université Claude Bernard Lyon 1, EA 7425, 69008, Lyon, France ;5.Departement of Functional Neurology and Epileptology, Hospices Civils de Lyon, Hôpital Neurologique, 69677, Bron, France ;6.Lyon Neuroscience Research Center INSERM U1058/CNRS UMR 5292, Université de Lyon, Université Claude Bernard Lyon 1, 69372, Lyon, France ;7.Neurology Department, Groupe Hospitalier Pitié-Salpêtrière, 75013, Paris, France ;8.Neuro-Oncologie, Hôpital Neurologique Pierre Wertheimer, 59 Boulevard Pinel, 69677, Bron Cedex, France ; |
| Abstract: | Journal of Neurology - To assess the long-term outcomes of patients with temporal lobe epilepsy and CSF anti-glutamate decarboxylase antibodies (GAD65-Abs). We retrospectively analyzed the clinical... |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |